Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
Diabetes mellitus (DM) is a common chronic disease affecting humans globally. During the last few years, the incidence of diabetes has increased and has received more attention. In addition to growing DM populations, DM complications are involving injuries to more organs, such as the heart and cereb...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2019/6430486 |
id |
doaj-0b5a91e05ffc4525ae63994704889009 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yingying Zhao Huichun Xing Xiaomei Wang Weini Ou Hong Zhao Ben Li Yue Li Ying Duan Liwei Zhuang Wei Li Danying Cheng Min Quan Yu Zhang Shibo Ji |
spellingShingle |
Yingying Zhao Huichun Xing Xiaomei Wang Weini Ou Hong Zhao Ben Li Yue Li Ying Duan Liwei Zhuang Wei Li Danying Cheng Min Quan Yu Zhang Shibo Ji Management of Diabetes Mellitus in Patients with Chronic Liver Diseases Journal of Diabetes Research |
author_facet |
Yingying Zhao Huichun Xing Xiaomei Wang Weini Ou Hong Zhao Ben Li Yue Li Ying Duan Liwei Zhuang Wei Li Danying Cheng Min Quan Yu Zhang Shibo Ji |
author_sort |
Yingying Zhao |
title |
Management of Diabetes Mellitus in Patients with Chronic Liver Diseases |
title_short |
Management of Diabetes Mellitus in Patients with Chronic Liver Diseases |
title_full |
Management of Diabetes Mellitus in Patients with Chronic Liver Diseases |
title_fullStr |
Management of Diabetes Mellitus in Patients with Chronic Liver Diseases |
title_full_unstemmed |
Management of Diabetes Mellitus in Patients with Chronic Liver Diseases |
title_sort |
management of diabetes mellitus in patients with chronic liver diseases |
publisher |
Hindawi Limited |
series |
Journal of Diabetes Research |
issn |
2314-6745 2314-6753 |
publishDate |
2019-01-01 |
description |
Diabetes mellitus (DM) is a common chronic disease affecting humans globally. During the last few years, the incidence of diabetes has increased and has received more attention. In addition to growing DM populations, DM complications are involving injuries to more organs, such as the heart and cerebral vessel damage. DM complications can reduce quality of life and shorten life spans and eventually also impede social and economic development. Therefore, effective measures to curb the occurrence and development of diabetes assist in improving patients’ quality of life, delay the progression of DM in the population, and ease a social burden. The liver is regarded as an important link in the management and control of DM, including the alleviation of glucose metabolism and lipid metabolism and others via glucose storage and endogenous glucose generation from glycogen stored in the liver. Liver cirrhosis is a very common chronic disease, which often lowers the quality of life and decreases life expectancy. According to a growing body of research, diabetes shows a close correlation with hepatitis, liver cirrhosis, and liver cancer. Moreover, coexistence of liver complications would accelerate the deterioration of patients with diabetes. Liver cirrhosis and diabetes influence each other. Thus, in addition to pharmacological treatments and lifestyle interventions, effective control of cirrhosis might assist in a better management of diabetes. When it comes to different etiologies of liver cirrhosis, different therapeutic methods, such as antiviral treatment, may be more effective. Effective control of cirrhosis might be a strategy for better management of diabetes. |
url |
http://dx.doi.org/10.1155/2019/6430486 |
work_keys_str_mv |
AT yingyingzhao managementofdiabetesmellitusinpatientswithchronicliverdiseases AT huichunxing managementofdiabetesmellitusinpatientswithchronicliverdiseases AT xiaomeiwang managementofdiabetesmellitusinpatientswithchronicliverdiseases AT weiniou managementofdiabetesmellitusinpatientswithchronicliverdiseases AT hongzhao managementofdiabetesmellitusinpatientswithchronicliverdiseases AT benli managementofdiabetesmellitusinpatientswithchronicliverdiseases AT yueli managementofdiabetesmellitusinpatientswithchronicliverdiseases AT yingduan managementofdiabetesmellitusinpatientswithchronicliverdiseases AT liweizhuang managementofdiabetesmellitusinpatientswithchronicliverdiseases AT weili managementofdiabetesmellitusinpatientswithchronicliverdiseases AT danyingcheng managementofdiabetesmellitusinpatientswithchronicliverdiseases AT minquan managementofdiabetesmellitusinpatientswithchronicliverdiseases AT yuzhang managementofdiabetesmellitusinpatientswithchronicliverdiseases AT shiboji managementofdiabetesmellitusinpatientswithchronicliverdiseases |
_version_ |
1725162293080096768 |
spelling |
doaj-0b5a91e05ffc4525ae639947048890092020-11-25T01:13:26ZengHindawi LimitedJournal of Diabetes Research2314-67452314-67532019-01-01201910.1155/2019/64304866430486Management of Diabetes Mellitus in Patients with Chronic Liver DiseasesYingying Zhao0Huichun Xing1Xiaomei Wang2Weini Ou3Hong Zhao4Ben Li5Yue Li6Ying Duan7Liwei Zhuang8Wei Li9Danying Cheng10Min Quan11Yu Zhang12Shibo Ji13Department of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDiabetes mellitus (DM) is a common chronic disease affecting humans globally. During the last few years, the incidence of diabetes has increased and has received more attention. In addition to growing DM populations, DM complications are involving injuries to more organs, such as the heart and cerebral vessel damage. DM complications can reduce quality of life and shorten life spans and eventually also impede social and economic development. Therefore, effective measures to curb the occurrence and development of diabetes assist in improving patients’ quality of life, delay the progression of DM in the population, and ease a social burden. The liver is regarded as an important link in the management and control of DM, including the alleviation of glucose metabolism and lipid metabolism and others via glucose storage and endogenous glucose generation from glycogen stored in the liver. Liver cirrhosis is a very common chronic disease, which often lowers the quality of life and decreases life expectancy. According to a growing body of research, diabetes shows a close correlation with hepatitis, liver cirrhosis, and liver cancer. Moreover, coexistence of liver complications would accelerate the deterioration of patients with diabetes. Liver cirrhosis and diabetes influence each other. Thus, in addition to pharmacological treatments and lifestyle interventions, effective control of cirrhosis might assist in a better management of diabetes. When it comes to different etiologies of liver cirrhosis, different therapeutic methods, such as antiviral treatment, may be more effective. Effective control of cirrhosis might be a strategy for better management of diabetes.http://dx.doi.org/10.1155/2019/6430486 |